Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals

Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals

It is unclear whether eradication of hepatitis C virus (HCV) leads to a reduction in the risk of hematologic malignancies. We aimed to determine the impact of sustained virologic response (SVR) induced by either direct‐acting antivirals (DAAs) or interferon (IFN) on the risk of hematologic malignanc...

Full description

Bibliographic Details
Main Authors: George N. Ioannou, Pamela K. Green, Kristin Berry, Solomon A. Graf
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1389

Similar Items

Similar Items